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Abstract
Background: Nucleosome assembly proteins (NAPs) are histone chaperones that are crucial for the shuttling and 
incorporation of histones into nucleosomes. NAPs participate in the assembly and disassembly of nucleosomes thus 
contributing to chromatin structure organization. The human malaria parasite Plasmodium falciparum contains two 
nucleosome assembly proteins termed PfNapL and PfNapS.
Methods: Three-dimensional crystal structure of PfNapS has been determined and analysed. Gene knockout and 
localization studies were also performed on PfNapS using transfection studies. Fluorescence spectroscopy was 
performed to identify histone-binding sites on PfNapS. Extensive sequence and structural comparisons were done 
with the crystal structures available for NAP/SET family of proteins.
Results: Crystal structure of PfNapS shares structural similarity with previous structures from NAP/SET family. Failed 
attempts to knock-out the gene for PfNapS from malaria parasite suggest essentiality in the parasite. GFP-fused PfNapS 
fusion protein targeting indicates cellular localization of PfNapS in the parasite nucleus. Fluorescence spectroscopy 
data suggest that PfNapS interacts with core histones (tetramer, octamer, H3, H4, H2A and H2B) at a different site from 
its interaction with linker histone H1. This analysis illustrates two regions on the PfNapS dimer as the possible sites for 
histone recognition.
Conclusions: This work presents a thorough analysis of the structural, functional and regulatory attributes of PfNapS 
from P. falciparum with respect to previously studied histone chaperones.
Background
In eukaryotic cells, DNA is present in a highly compacted
form called chromatin. The repeating unit of chromatin
is the nucleosome, formed from two histone H2A-H2B
dimers and one histone H3-H4 tetramer around which
147 bp of DNA are wrapped [1]. Chromatin is highly
dynamic, a characteristic that is vital in regulating nuclear
processes such as transcription and replication which
require access to DNA. Processes that influence chroma-
tin fluidity include post-translational modifications of
histones, incorporation of histone variants, and histone
exchange by dedicated histone chaperones [2,3]. Histone
chaperones are proteins that regulate the interaction of
histones with other proteins and DNA and also prevent
the highly basic histones from forming inappropriate
aggregates [2,3]. In addition to playing an important role
in histone exchange during nuclear processes, histone
chaperones function in nucleocytoplasmic shuttling of
histones, in histone storage, in nucleosome assembly and
they act as a link between chromatin remodeling factors
and histones [2,3]. Many different histone chaperones
have been identified, including nucleoplasmin, Asf1
(anti-silencing function 1), HIRA proteins (Histone regu-
lator A), Spt6 (Transcription elongation factor), ACF
(ATP utilizing chromatin assembly and remodelling fac-
tor), CAF1 (Chromatin assembly factor 1), and NAP1
(nucleosome assembly protein 1) [2,3].
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Page 2 of 15Malaria is one of the most common infectious diseases
and remains an enormous public health problem. Malaria
is caused by protozoan parasites of the genus Plasmo-
dium, and the most serious form of the disease is caused
by Plasmodium falciparum [4]. Thus, it is important to
understand the fundamental biological processes of P. fal-
ciparum, which may provide avenues for the identifica-
tion of new protein targets for development of new anti-
malarials. The human malaria parasite P. falciparum con-
tains two nucleosome assembly proteins, orthologs of
eukaryotic NAPs, which have been previously termed
PfNapL and PfNapS [5-8]. It has been previously shown
that both PfNapL and PfNapS are present in all erythro-
cytic stages of the parasite [5,6]. It has also been shown
earlier that PfNapS forms complexes with both histone
tetramer and octamer and is predominantly localized in
the nucleus in the asexual and sexual stages of the para-
site [5,6]. PfNapL and PfNapS do not interact with each
other and unlike PfNapL, PfNapS is able to deposit his-
tones onto DNA [6].
In the present study, the structural basis of nucleosome
assembly activity in P. falciparum was addressed by deter-
mining and analysing the crystal structure of smaller
NAP in the parasite called PfNapS. Data are presented on
the attempted gene knockout of PfNapS, its cellular local-
ization and its histone binding properties. Attempts to
generate parasites lacking PfNapS gene were unsuccessful
indicating the likely essential nature of this gene for para-
site survival. Using GFP-fused PfNapS deletion con-
structs, it is shown that PfNapS is most likely resident in
the parasite nucleus. Fluorescence spectroscopy data
indicate differential modes of PfNapS interaction with
core histones versus the linker histone. Finally, a thor-
ough comparative analysis of PfNapS is presented with
structures of NAP/SET family proteins which include -
PfNapL, yeast NAP-1, yeast NAP Vps75 (vacuolar protein
sorting 75) and the functional domain of human SET/
TAF-1b(β)/INHAT [7-12]. These studies provide basis
for further exploration of nucleosome assembly as a rele-
vant new target for development of anti-malarials.
Methods
Protein crystallization and data collection
Full length purified PfNapS protein (aa 1-269, molecular
weight ~32 kDa) failed to crystallize and thus a shorter
construct of PfNapS was produced containing residues
29-221. PfNapS seleno-met crystals were then success-
fully obtained at 20°C by hanging drop vapour diffusion
[13] using l μl of 3 mg/ml PfNapS and l μl of 0.2 M di-
ammonium tartrate with 20% PEG 3350 (mother liquor).
A single crystal was soaked in a cryoprotectant contain-
ing higher concentration of mother liquor (30% PEG 3350
and 0.3 M di-ammonium tartrate) for 5 min and flash-
frozen under a stream of nitrogen gas at 100 K. X-ray dif-
fraction data were collected to 3.2 Å at BM14 beamline,
ESRF, Grenoble. The seleno-met crystals of PfNapS
belong to orthorhombic space group P212121 with cell
dimensions of a = 96.18, b = 116.84, c = 138.65 Å having 3
dimers in the asymmetric unit (ASU). High-resolution
native diffraction data to 2.8 Å resolution were collected
at BM14 beamline, ESRF, Grenoble. These crystals also
belong to orthorhombic space group P212121 with differ-
ent cell dimensions of a = 95.79, b = 114.89, c = 139 Å.
The diffraction images were processed and scaled with
the HKL2000 suite [14].
Phasing, structure determination, refinement and analysis
The structure of PfNapS was determined using selenium-
SAD technique and phasing was achieved by utilizing a
total of 24 selenomethonines (8 per dimer) in the ASU to
3.2 Å resolution using SHARP [15]. Only a partial initial
model was built without side-chains using PHENIX [16]
and this model was subsequently rebuilt manually using
COOT [17]. The higher resolution structure was deter-
mined by molecular replacement technique using PfNapS
seleno-met model. This model to 2.8 Å was refined using
CNS ([18], Table 1). Final model was validated using
PROCHECK [19]. All figures were generated using Chi-
mera [20]. Least square fittings and structural alignment
were carried out using LSQMAN [21]. Protein localiza-
tion predictions were done using LOCtree [22].
Generation of plasmids and transgenic P. falciparum cell 
lines
Transgenic parasites expressing GFP chimeras were gen-
erated by cloning either the full length PfNapS coding
region or truncated portions of it into the pARL vector
[23], where expression of chimeric protein is under the
influence of the crt promoter. Each DNA construct was
confirmed by sequencing. 100 ug plasmid DNA (Qiagen)
was transfected by electroporation into P. falciparum 3D7
parasites which were cultured in the presence of 2 nM
WR99210 [24]. To generate a PFI0930c (PfNapS gene)
deletion construct 5' and 3' targeting sequences were
amplified using the primer pairs aw771/772 and aw773/
774 respectively. The amplified targeting sequences (613
bp and 530 bp) were cloned into pCC-1 vector [25] using
SacII/SpeI for the 5' and EcoRI/AvrII for the 3' segment,
resulting in the pCC-1ΔPfNapS plasmid.
(aw771: atcccgcggATCACATTGTAATTAAGC;
Aw772: gatactagtGAAAGGCATCAAAGGATCATC;
Aw773: atcgaattcGTGCCCATGAACAAATGAAC;
Aw774: gatcctaggCATCAAATTCTTCTAAGCC)
The plasmid DNA was proliferated in Escherichia coli
PMC103 cells and purified with a Qiagen Maxit kit,
before 80 ug were taken up in cytomix and electroporated
into 3D7 P. falciparum infected human erythrocytes (O+)
using standard procedures [24]. Parasites were cultured
Gill et al. Malaria Journal 2010, 9:90
http://www.malariajournal.com/content/9/1/90
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Parameter Native Seleno-Met
Data collection
Space group P212121 P212121
Cell Dimensions (Å) a = 95.79, b = 114.89, c = 139 a = 96.18, b = 116.84, c = 138.65
Wavelength (Å) 1.0 1.0
Anomalous scatterer - Se
Resolution (Å) 50.0-2.8 50.0-3.2
Outer shell resolution (Å)a 2.9-2.8 3.31-3.2
No. of unique reflections 37166 (3101) 24009 (1781)
Redundancy 5.9 5.8
Rmergeb 0.68 (0.295) 0.142 (0.653)
Completeness (%) 100 (96.6) 99.7 (69.6)
I/σI 23.5 (3.1) 10.16 (1.2)
Refinement
Resolution range (Å) 50-3.0
No. of reflections (test set) 35024 (3501)
0
Rfactor/Rfree (%) 28.5/31.5
No. of residues 1006
No. of water molecules 358
B factor (Å2)
Protein atoms 64.6
Water atoms 45.0
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plasmid were selected in the presence of 2 nM WR99210
[26]. The resulting parasite population was then sub-
jected to two off/on drug cycles for 21 days each to
encourage the loss of free plasmid. After each addition of
WR99210, a subpopulation was selected on 231 nM 5-
fluorocytosine in the presence of WR99210 (to encourage
double recombination events) and analysed via Southern
blot.
SDS-PAGE and western blotting
Parasite cultures were synchronized by sorbitol treatment
[27] and saponin pellets of trophozoite parasites were
prepared. The parasite-derived proteins were fraction-
ated on a 10% Bis-Tris precast gel (Invitrogen) using
MOPS buffer. Proteins were electrophoretically trans-
ferred to a nitrocellulose membrane (0.22 um, Millipore)
before western blot was performed using standard proce-
dures. Antibodies used were mouse anti-GFP (1:1000,
Roche) and horseradish peroxidase-coupled sheep anti-
mouse IgG (1:2000, Chemicon, Melbourne, Australia).
Protein bands on the western blots were visualized using
a chemiluminescent substrate (ECL, GE).
Microscopy
GFP-expressing infected erythrocytes were tightly syn-
chronized using sorbitol and studied live at ambient tem-
perature. Cells were viewed with a Plan-Neofluar 100×
1.3 oil objective on a Zeiss Axiovert 200 M Live Cell
Imaging Inverted Microscope equipped with a AxioCam
MRm camera and primarily processed with AxioVision
4.4 deconvolution software package. Captured images
were then further processed using Photoshop and ImageJ
software [28]. Pictures were adjusted to gain optimal con-
trast to visualize features of interest.
Protein expression, purification, fluorescent labeling and 
ELISA-based binding studies
All histones (purchased from Roche diagnostics) were
dissolved in autoclaved distilled water. PfNapS protein
was expressed and purified using standard protocols
described previously [5,6]. Site directed mutagenesis was
carried out using QuickChange® II Site-Directed Muta-
genesis Kit. PfNapS was labelled with 6-acryloyl-2-dime-
thyl-aminonaphthalene (acrylodan) dye (from
Invitrogen) using the protocol described by Prendergast
et al [29] and Hibbs et al [30] with a few modifications.
Acrylodan dye is an extrinsic fluorophore and its fluores-
cence emission is highly sensitive to its local microenvi-
ronment when bound to the protein. It exhibits changes
in both intensity and emission wavelength that reflects
the effective dielectric constant of the microenvironment
around the fluorophore. PfNapS was labelled with the dye
using the protocol described by Prendergast et al [29] and
Hibbs et al [30]. Stock concentration of dye was prepared
in dimethyl formamide. Purified protein was incubated
with excess of dye in phosphate buffer (50 mM, pH = 7.5)
overnight in the dark at 4°C. Unbound dye was removed
using Superdex® 75 10/300 GL (GE healthcare). Binding of
labelled PfNapS with H3 and linker histone H1 was stud-
ied using similar protocols described previously [6].
Steady state fluorescence measurement
Steady state fluorescence measurement was taken on Per-
kin Elmer LS50B fluorescence spectrophotometer. The
sample was titrated with histones H3, H4, H2A, H2B, his-
tone tetramer { [(H3-H4)2]} and histone octamer (two
heterodimers of H2A-H2B and a tetramer of H3-H4).
Fluorescence of buffer was subtracted as control. Excita-
tion was done at 360 nm and emission was scanned from
400 to 550 nm. Both the slits were 5 nm wide open and
the scan speed was set to 100 nm per minute. All fluores-
Stereochemistry
rmsd bond length (Å) 0.01
rmsd bond angle (°) 1.6
Ramachandran Plot
Prefered regions (%) 66.9
Allowed regions (%) 33.1
a Numbers in parentheses are values in the highest resolution shell.
b Rmerge =  | Iobs - <I>|/ <I> summed over all observations and reflections
Table 1: Data collection and refinement statistics (Continued)
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replicate experiments.
Results and Discussion
Structure determination of PfNapS and structural 
comparisons with PfNapL, hSET, yNAP-1 and Vps75
A construct of PfNapS consisting residues 29-221 (molec-
ular weight ~23 kDa) crystallized in orthorhombic space
group P212121 with solvent content of 55% (the asymmet-
ric unit contains three dimers of PfNapS). Crystal struc-
ture of PfNapS was determined using selenium-SAD
(single anomalous dispersion) technique at 3.2 Å and
refined using native data to 2.8 Å resolution (Table 1).
Most residues of PfNapS exhibited clear electron density.
Four C-terminal residues (aa 218-221) were disordered as
were regions 142-150 and 168-181. The final refined
model of PfNapS has Rfactor and Rfree values of 28.2% and
31.45% respectively (Table 1). The domain architecture
and the overall fold of PfNapS are similar to PfNapL,
yNAP-1, hSET and Vps75 [7-12] (Figure 1a-b, 2a-c).
Functional, cellular localization and sub-domain proper-
ties of these five structures are summarized in Table 2
and 3[6,7,31-33]. Each monomer of PfNapS contains
domain I comprised of dimerization helix α2 (aa 33-73).
The monomer also contains domain II, which is com-
prised of α-helices [α3 (aa 81-85), α4 (aa 99-102)] and a β
sub-domain containing 4 anti-parallel β-strands (aa 106-
158). The 4th β-strand in PfNapS is composed of a ran-
dom coil similar to hSET. Finally, there are two α-helices
on the opposite side of the β sub-domain [α7 (aa 200-211
and α8 (aa 214-216)] (Figure 1b). It was observed that
each of the six chains of PfNapS in crystallographic asym-
metric unit differ mainly in the orientation of their
dimerization helix α2 and the loop regions between the
β-strands in the β sub-domain suggesting possible points
of flexibility.
The PfNapS dimer has a characteristic shape and fold
previously seen for yNAP-1, Vps75, hSET and PfNapL
dimers (Figures 1a-b, 2a-c) [7-12]. In PfNapS, 23 residues
of the dimerization helix α2 and four residues of α7 and
α8 (which lie in domain II) contribute to dimer formation
via hydrogen bonding and hydrophobic interactions
(Asp32, Phe33, Ile36, Gln37, Ile40, Leu43, Asp44, Lys45,
Cys47, Glu50, Gln51, Ile54, Gln55, Gln57, Tyr58, Lys61,
Lys62, Leu65, Phe66, Lys68, Arg69, Ile72, Ile73 and
His210, Pro212, Leu313, Leu217 respectively). The over-
all sequence identity of PfNapS with yNAP-1, Vps75,
hSET and PfNapL is 20, 17, 25 and 18% respectively. Sim-
ilar to PfNapL and other NAPs in the malaria parasite [7],
PfNapS is also evolutionary distant from homologs in
yeast and human (Additional file 1). The length of the
dimerization helix α2 varies in all the five proteins and
PfNapS has the shortest such helix comprising of 41 resi-
dues (Table 2). The root mean square deviation (r.m.s.d)
of PfNapS with yNAP-1, hSET, Vps75 and PfNapL is 1.9,
1.6, 2.0 and 1.9 Å respectively (Table 2; Figure 2a-c).
PfNapS exhibits the highest sequence identity (25%) as
well as structural similarity with hSET. Also, the r.m.s.d.
of PfNapS is lowest with hSET at 1.6 Å indicating high
structural identity (Table 2; Figure 2a, b). The N-terminal
in PfNapS (aa 1-28) is missing in the present construct
whereas in hSET the N-terminal is ordered (aa 1-15) and
forms a helical structure α1 (aa 2-12). The region 195-200
of domain II in hSET is disordered and its corresponding
region (aa 191-196) in PfNapS has weak electron density.
The helices α7 and α8 on side of the β sub-domain of
PfNapS are similar in length and orientation to hSET.
Interestingly, the disorder in the present structure of
PfNapS is also closest to hSET structure (Figure 2a, b).
Table 2: Localization details of PfNapS, PfNapL, hSET, yNAP-1 and Vps75.
Protein, PDB code Annotation Localization r.m.s.d of Cα, Å (number of Cα 
matched)
Length of dimerization helix 
α2 (r.m.s.d, Å)
PfNapS, 3KYP malaria parasite NapS Primarily nuclear 41
PfNapL, 3FS3[6-8] Malaria parasite NapL Primarily cytoplasmic 1.94 (144) 51 (0.9)
hSET, 2E50[10,31] Human
SET/TAF-Iβ/INHAT 
functional domain
Nucleocytoplasmic 1.6 (139) 54 (0.75)
yNAP-1, 2AYU[9,32] Yeast NAP-1 Nucleocytoplasmic 1.9 (112) 51 (1.0)
Vps75, 3CDM[11,12,33] Yeast NAP Primarily nuclear 2.0 (124) 42 (0.9)
Comparison of root mean square deviation (r.m.s.d) of NAP/SET monomers and length of dimerization helix α2 with PfNapS monomer.
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and Vps75 is 20 and 17% respectively. The differences
with respect to yNAP-1 and Vps75 are in the overall
structural orientations of secondary structures (Table 2;
Figure 2a, c). The major difference with yNAP-1 is
absence of the 'accessory domain' in PfNapS. It has been
earlier shown that this 'accessory domain' is absent in
PfNapS, PfNapL and their homologs from other Plasmo-
dium species [7]. A sequence comparison of PfNapS with
other apicomplexan parasites like Toxoplasma, Babesia
and Theileria revealed that this domain region is absent
in them too (Additional file 2). Since the 'accessory
domain' is absent in Vps75 and hSET as well (which are
primarily localized in the nucleus), it remains unclear
what role this domain plays in nuclear shuttling of these
proteins, as was suggested for yNAP-1 [7-9]. The region
168-181 of PfNapS is disordered, however, Vps75 has an
ordered helical content in this region (aa 153-176) and
yNAP-1 has anti-parallel β-strands containing the
nuclear localization signal (NLS). Also, comparisons with
the identified NLS in yNAP-1 have revealed that PfNapS
lacks an NLS which is also the case for Vps75.
A sequence alignment of PfNapS with other homologs
from Plasmodium species (Plasmodium vivax, Plasmo-
dium berghei, Plasmodium knowlesi, Plasmodium yoelii
and Plasmodium chabaudi) revealed high sequence con-
servation amongst them (75-90%). Further analysis
showed that the N-terminal exhibits lower conservation
but the C-terminal contains acidic stretches in all of these
proteins (Additional file 1). Dimer contributing residues
of the dimerization helix α2 and domain II are well con-
served in all structural homologs. Residues implicated in
Table 3: Comparison of pI (isoelectic point) of sequence stretches for all the 5 crystal structures
pI (isoelectric point) Entire protein 
sequence
Protein sequence 
crystallised
Missing N-terminal Missing C-terminal
PfNapS 4.4 5.4 5.2 3.0
PfNapL 5.0 7.0 4.9 3.3
hSET 4.2 4.9 - 2.6
yNAP-1 4.3 4.5 5.2 3.5
Vps75 4.9 5.2 3.4 3.4
Figure 1 Overall structure of PfNapS. (a) Domain diagram for NAP/SET crystal structures determined so far. Architecture of PfNapS, yNAP-1, Vps75, 
hSET and PfNapL highlighting the 'accessory domain' in yNAP-1 (coloured yellow) which is missing in the remaining 4 structures (set to scale). (b) 
Structure of the PfNapS dimer. Each monomer of PfNapS contains domain I comprised of dimerization helix α2 and domain II comprised of a β sub-
domain (4 anti-parallel β strands) and α-helices.
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PfNapS suggesting variable binding site for histones [7].
Also, a comparison of the residues from hSET mutagene-
sis data revealed that corresponding residues in PfNapS
and its homologs from Plasmodium and other apicompl-
exans show overall weak conservation (Additional file 1).
Gene knockout studies of PfNapS and its localization in the 
parasite
To assess the role of PfNapS in vivo, disruption of the cor-
responding gene was attempted from genome of P. falci-
parum 3D7 strain. Despite several attempts, the gene
could not be disrupted indicating an essential role for this
gene (Additional file 3). This observation is consistent
with unsuccessful attempts to disrupt NapS in the murine
malaria parasite P. berghei [34]. Due to the current tech-
nological limitations imposed by the Plasmodium sys-
tems, the essentiality of PfNapS could not be formally
proven; however, these results provide circumstantial evi-
dence for a very important role played by PfNapS. Gene
knockout phenotypes in several other studied organisms
have indicated the essentiality of nucleosome assembly
proteins. It has been shown that gene ablations in mouse
and Drosophila cause embryonic lethality whereas in
yeast cells exhibit growth defects [35-37]. Therefore, it is
not surprising that the malaria parasite likely requires
this gene for survival.
It has been earlier shown that PfNapS is expressed dur-
ing all parasite blood stages, and immunofluorescence
assays suggested a close association of PfNapS with para-
site nucleus [5,6]. To address the issue of potential
sequences within PfNapS which might target this protein
to the parasite nucleus (in the absence of a clear NLS
motif ), full-length PfNapS was fused with green fluores-
cence protein (GFP) and these gene fusions were
expressed episomally in wild-type parasite. The protein
chimeras showed a nuclear localization in all stages of
erythrocytic life-cycle as determined by co-localization
with the nuclear stain DAPI (4', 6-diamidino-2-phenylin-
dole; nuclear stain) (Figure 3a, c-f). Western blot analysis
using anti-GFP antibodies confirmed the expression of
fusion proteins (Figure 3b). All fused proteins ran at the
Figure 2 Comparison of PfNapS with yNAP-1, Vps75, hSET and PfNapL (a). Structure-based sequence alignment of PfNapS, yNAP-1, Vps75, hSET 
and PfNapL. Residues constituting α-helices and β-sheets in all the individual structures are coloured magenta and green respectively. Domains I and 
II of PfNapS are indicated using blue and green bars respectively. Conserved hydrophobic motifs are dotted underlined in purple and indicated as 
'motif I' and 'motif II'. The 'accessory domain' of yNAP-1 is foreground coloured yellow. The predicted NES and NLS motifs in yNAP-1 are shown in a 
shaded box coloured grey. The corresponding NES and NLS motifs in PfNapL are also shown in a shaded box coloured grey. Disordered/missing res-
idues are in small caps and coloured grey. Residues that could not be aligned are shown in italics. (b) Superposition of PfNapS dimer structure (orange) 
onto hSET (PDB code: 2E50, green) and PfNapL (PDB code: 3FS3, purple). (c) Superposition of PfNapS dimer (coloured orange) onto hSET (PDB code: 
2E50, green) and yNAP-1 (PDB code: 2AYU, purple). The 'accessory domain' of yNAP-1 which is absent in others is coloured blue.
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resulted in a band at around 29 kDa rather than the pre-
dicted 34 kDa. One possible explanation might be the rel-
ative high content of glutamines and glutamic acids in
this fusion protein resulting in aberrant protein mobility.
The three truncated forms consisting of aa1-30-GFP,
aa30-90-GFP and aa90-269-GFP (Figure 3a) showed dif-
ferent localizations in live cell fluorescence microscopy:
aa90-269 showed a similar nuclear localization to the full-
length chimera, whereas aa1-30-GFP and aa30-90-GFP
showed fluorescence in the parasite cytoplasm. There-
fore, it seems likely that the region responsible for target-
ing PfNapS to the nucleus is contained within PfNapS
residues 90-269. The localization of these fusion proteins
did not alter during the parasite life-cycle stages in immu-
nofluorescence assays (Additional file 3). In the well-
studied yeast NAP (yNAP-1), residues 290-295
('RKQRNK') have been experimentally identified as an
NLS [9]. It has been previously shown that the corre-
sponding region in PfNapL (aa 203-207, 'KKQHNK') is
disordered in the crystal structure, and in any case
PfNapL seems resident in the parasite cytoplasm [7]
(Table 2; Figure 2a). In the case of nuclear associated
PfNapS, the corresponding region is again disordered (aa
172 to 177-'NRSDLD') [7,9] (Table 2, Figure 2a-b). There-
fore, GFP-fusion transfection data suggest that PfNapS
likely contains NLS-like motif in residues 90-269 but the
set or sets of motifs, which direct PfNapS to the nucleus
remain to be discovered.
PfNapS-histone interaction using fluorescence 
spectroscopy
Structural analysis reveals two free surface exposed
cysteine residues (Cys47 and Cys154) in PfNapS dimer.
The first residue Cys47 is present at concave region of the
dimerization helix α2 whereas Cys154 is present on outer
surface of domain II (Figure 4a). These cysteines were
labelled on PfNapS using molecular environment sensi-
tive dye 6-acryloyl-2-dimethyl-aminonaphthalene (acry-
lodan) which binds covalently to surface exposed cysteine
residues. Post modification, the tagged protein (PfNapS-
dye) was passed through gel filtration column to remove
unbound dye. PfNapSdye was then used in histone interac-
tion studies. Upon titrating PfNapSdye with histone
monomers and histone oligomers a gradual blue shift was
observed along with an increase in the quantum yield
(Figure 4b). This chromic shift reaches a saturation level
and then no further blue shift or increase is observed
upon addition of either the same histone or a different
one. These data suggest embedding of the tagged
cysteines upon binding of PfNapSdye to histones. Such
interaction likely causes transition of dye from a polar
(fully exposed to solvent) to a non-polar environment (i.e.
burial at Nap-histone interface).
To further investigate probable histone binding
region(s) on PfNapS, these two surface cysteine residues
on PfNapS were mutated independently (mutants are
referred to as C47A and C154A). On plotting the change
in fluorescence as a function of histone concentration, it
was observed that in the absence of histone, the chromic
shift was similar for these mutants. This analysis suggests
that both the cysteine residues experienced same solvent
environment. Upon adding histones, a blue shift was
observed along with an increase in the quantum yield
suggesting that C47A and C154A might play a role in his-
tone binding. However, a higher change in the chromic
shift in C154A (about two times) in comparison to C47A
(Figure 4d) possibly suggests a bigger role of C154A in the
binding interaction.
Interestingly, no chromic shift or increase in the quan-
tum yield in fluorescence was observed on titrating the
PfNapSdye with linker histone H1 indicating no change in
the dielectric constant of the microenvironment around
the fluorophore (Figure 4e). These data suggest a differ-
ent mode and/or region of binding of linker histone H1 to
PfNapS as opposed to the core histones. To rule out the
possibility that the dye could be affecting binding of his-
tone H1 to PfNapS, interaction of labelled PfNapS with
histone H1 was analysed and compared it with binding
with histone H3. No significant difference was observed
in binding of these histones to PfNapS (Figure 4c). These
data are in agreement with previously published work,
which suggested differential binding of NAPs to linker
histone H1 when compared with core histones and his-
tone oligomers [38,39]. Interestingly, no clear homolog
for histone H1 has been identified in Plasmodium or
indeed in any apicomplexan organism so far. However,
histone H1 sequences tend to vary and it is likely that
their overall structure is more conserved. It would be very
unusual if apicomplexans lacked linker histone H1 alto-
gether. The above experiments were done with all canon-
ical histones with the assumption that apicomplexans will
have a structural homolog of linker histone H1.
Comparison of histone binding characteristics of NAP/SET 
structures
Mutagenesis studies performed previously on hSET had
revealed important residues in domain II that affect the
binding of hSET to both core histones and dsDNA [10].
These residues were mapped onto the PfNapS dimer and
most of the corresponding ones are not conserved with
hSET except for Lys163 and Thr190 (Table 4). Only six of
the 12 residues that affect binding of hSET to histones
(completely or to a marginal extent) are conserved in
PfNapS. In the previous study on the cytoplasmically res-
ident PfNapL, six residues of PfNapL were mutated based
upon the hSET mutagenesis data and it was shown that
these six had no effect on the binding of PfNapL to his-
Gill et al. Malaria Journal 2010, 9:90
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Figure 3 Stage specific expression of PfNapS-GFP chimeras (a). Deletion constructs of PfNapS-GFP. (b) Western blot analysis of transgenic P. fal-
ciparum cell lines expressing GFP-tagged versions of PfNapS with antibodies against GFP. PfHsp-70 expression was detected as a loading control. Lo-
calization of (c) PfNapS-full length-GFP (d) aa1-30-GFP (e) aa30-90-GFP and (f) aa90-269-GFP in parasite merozoite, ring, trophozoite, late-trophozoite 
and schizont stages. The first column shows DIC (Differential Interference Contrast) images, followed by images with a nuclear DAPI stain, GFP fluo-
rescence, an overlay of the nuclear and the GFP localization and overlay of all four images.
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Figure 4 PfNapS-histone interaction studies using fluorescence spectroscopy (a). PfNapS dimer is shown as molecular surface. Domains I and II 
are coloured blue and green respectively. The residues Cys47 and Cys154 are coloured red and yellow and are indicated. (b) Fluorescence emission 
spectra of PfNapS in presence of increasingconcentrations of histones. A hypsochromic shift (blue shift) was observed onbinding of histones. However 
in case of histone H1 no such change wasobserved. Fluorescence intensity was measured after incubating75 micro gram of PfNapS protein with 5, 
10, 15, 20, 25, 30, 35, 40, 45, and 50 micrograms ofhistones. All experiments were repeated thrice. (c) Effect of labeling on binding of PfNapS to histones 
H3 and H1. (d) Graph representing hypsochromic shift (F460/485) in fluorescence of two PfNapS mutants as a function of amount of H3 histone. (e) 
Graph representing differential binding of linker histone H1 with respect to core histones. There is no shift in fluorescence on binding of H1, however, 
core histones show hypsochromic shift (F460/485) in fluorescence.
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Page 11 of 15tones [7]. These six residues are mostly conserved
amongst PfNapL and PfNapS with only the residues
His227 and Tyr259 of PfNapL replaced in PfNapS by glu-
tamine and proline residues respectively (Table 5). Three
residues of PfNapL have been earlier identified that
potentially contribute to histone recognition, based on
Asf1-histone complex analysis [7,40,41]. Although two of
these residues of PfNapL are not conserved in PfNapS,
the third is in fact an alanine in PfNapL and a cysteine
(Cys154) in PfNapS. Interestingly, new fluorescence data
indicates a role for region encompassing this cysteine
(Cys154) in interaction with all core histones, except with
linker histone H1. In summary, the studies on PfNapL
and PfNapS together suggest a region or regions in
domain II of nucleosome assembly proteins which likely
contribute to histone recognition.
Phosphorylation status
It has been earlier shown that both PfNapL and PfNapS
are phosphorylated by casein kinase II (CKII) [5,6]. Pro-
grams NetPhos and NetPhosK predicted phosphoryla-
tion sites on PfNapS of which three residues Ser91,
Thr190 and Thr191 (CKII phosphorylation site) are sur-
face exposed in the structure. All these residues have cor-
responding serine and/or threonine residues respectively
in hSET and PfNapL, which are also surface exposed.
However, the site Ser91 of PfNapS is replaced by cysteine
and alanine residues and Thr190 is replaced by aspartate
and arginine residues in yNAP-1 and Vps75 respectively.
Thus, the phosphorylation sites predicted for PfNapS are
conserved in PfNapL and in hSET but not in yNAP-1 and
Vps75. Further, the three phosphorylation sites which
have been earlier identified for yNAP-1 lie in the 'acces-
sory domain' region which is absent in PfNapS, PfNapL,
Table 4: Structure-based comparison with hSET mutagenesis data of residues which effect binding (completely or 
partially) to histones
hSET PfNapL PfNapS Vps75 yNAP-1
1 S162 D192 E161 Q150 D278
2* K164 K194 K163 D152 H281
3 D165 N195 N164 S153 N282
4 T191 H227 E187 G181 N314
5* T194 T230 T190 R184 D317
6 D195 (disordered) S231 T191 W185 D317
7 D202 Y259 P198 D198 Y342
8* E203 E260 D199 S199 S343
9* E206 L263 E202 S202 E246
10* K209 K266 R205 S205 K349
11 D210 E267 R206 E206 D350
12* D211 R268 E207 E207 K351
13 E187 (disordered) D223 W183 K177 E320
*conserved in PfNapS
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dues for Ser184 of PfNapS that lie in the conserved
hydrophobic motif (SIFEWF) are conserved and surface
exposed in all the five structures and could possibly rep-
resent a common phosphorylation site for NAP/SET pro-
teins (Figures 2a, 5c). This conserved residue is not a
predicted CKII site on any of these five proteins but
nonetheless may be of significance given its conservation
in these proteins.
In summary, these comparative structural analyses
show that PfNapS, PfNapL, hSET, yNAP-1 and Vps75
contain conserved residues in the dimerization helix
which contribute to dimer formation in all these five pro-
teins (Table 6 and Figure 5a). Functional data on PfNapS
indicate the inability to delete PfNapS gene suggesting its
essentiality in the parasite. Transfection studies identify
parasite nucleus as the site for localization of PfNapS.
Fluorescence data analysis highlights two regions on
PfNapS dimer which are likely to contribute to histone
recognition (Figure 5b). Finally, it is likely that the region
for histone recognition on NAPs and SET domains may
be the outer face of domain II and base of the cavity in the
underside of each dimer (Figure 5b).
Yeast two-hybrid studies on interacting partners of
PfNapS suggest a crucial role for this protein in numerous
protein networks [42]. A total of 27 proteins have been
shown to interact with PfNapS [42]. However, in the
absence of independent experimental validation of each
of these protein-protein interactions, it is premature to
speculate on their biological relevance. Nonetheless, an
attempt was made to classify these binding partners for
PfNapS. Analysis suggests that three of the 27 proteins
are predicted to be localized to the parasite nucleus
(Additional file 4). Further, a total of six of 27 proteins are
likely to be involved in chromatin modelling (Additional
file 4). The crystal structures of these interacting proteins
are unknown and, therefore, their binding modes with
PfNapS remain unexplored. Clearly, these studies pre-
sented here pave the way for deeper dissection of numer-
ous protein-proteins interactions that occur with PfNapS.
Conclusions
The on-going structural, biochemical, gene knockout and
localization studies on the two nucleosome assembly pro-
teins from P. falciparum have revealed similar three-
dimensional structures for the two proteins whilst having
different localizations within the parasite. Based on
Table 5: Structure-based comparison with PfNapL mutagenesis data
PfNapL PfNapS Vps75 yNAP-1 hSET
Effect binding
1 I136 N112 S95 - F115
2 I147 K120 S104 K230 R123
No effect on binding to PfNapL PfNapS Vps75 yNAP-1 hSET
1* D192 E161 Q150 D278 S162
2 H227 E187 G181 N314 T191
3* T230 T191 R184 D317 T194
4 Y259 P198 D198 Y342 D202
5* E260 D199 S199 S343 E203
6* K266 R205 S205 K349 K209
7 D223 W183 K177 E320 Disordered
*conserved in PfNapS
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Page 13 of 15extensive experimental analysis on both malaria parasite
nucleosome assembly proteins, it is suggested that this
critical pair of proteins provide a unique opportunity for
the exploration as anti-malarial targets.
Protein Data Bank Accession Code
The coordinates have been deposited in the public data-
bank with PDB code 3KYP.
Table 6: Conserved residues in PfNapS, PfNapL, yNAP-1, hSET and Vps75 which contribute to dimer formation
Conserved in all 5 proteins Conserved in 4 of 5 Conserved in 3 of 5
PfNapS residues I40, L43, K46, C47, E50, Q51, I54, Q57, Y58, 
K61, K62, L65, K68, R69, I73, I73
D32, F33, I36, D44, Q55, F66 Q37
Figure 5 Overall structural, functional and regulatory comparisons between NAP/SET proteins based upon 5 crystal structures [7-12]. (a). 
PfNapS dimerization helix α2 is shown as molecular surface. Conserved dimer contributing residues between all 5 crystal structures are mapped onto 
PfNapS. Residues from chains A and B are coloured blue and green respectively and residues from chain A are labelled. (b) hSET is shown as molecular 
surface and coloured brown. Residues from hSET mutagenesis analysis are coloured green and corresponding residues from PfNapL mutagenesis are 
coloured blue. The corresponding residues for the two cysteines from PfNapS fluorescence data are coloured cyan and are indicated with arrows. (c) 
PfNapS dimer is shown as molecular surface and coloured sky blue and the conserved hydrophobic motif is coloured blue. Surface exposed serine 
residue is coloured red.
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